Opportunities and Challenges in Translating Genomics into Population Health Impact: Lessons from Familial...

Area of Science:

• Genomic Medicine
• Cardiovascular Disease Prevention
• Public Health

Background:

• Familial hypercholesterolemia (FH) is a common, autosomal dominant genetic disorder causing lifelong high LDL cholesterol and premature cardiovascular disease.
• Despite effective therapies and evidence for early treatment benefits, FH is historically underdiagnosed and undertreated globally.
• This gap underscores challenges in translating genomic discoveries into population health impact.

Purpose of the Study:

• To review initiatives advancing FH awareness, identification, surveillance, and genomic medicine implementation in cardiovascular disease prevention.
• To evaluate progress, identify barriers, and recommend strategies for strengthening FH detection, treatment, and prevention efforts using the Essential Public Health Services framework.
• To draw lessons from the FH experience for other genomic conditions to achieve public health benefits.

Main Methods:

• Review of initiatives by CDC, Family Heart Foundation, and stakeholders.
• Application of the Essential Public Health Services framework (assessment, policy development, assurance/implementation).
• Evaluation of progress, barriers, and opportunities for FH management.

Main Results:

• Initiatives have advanced FH awareness, case identification, surveillance, and evidence-based care.
• Progress in implementing genomic medicine for cardiovascular disease prevention has been made.
• Implementation barriers and opportunities for FH detection and treatment have been identified.

Conclusions:

• Achieving public health benefits from genomic conditions requires more than scientific discovery.
• Increased investment in implementation science, health equity, and sustained systems-level engagement is crucial.
• Translating genomic knowledge into scalable population health improvements necessitates a comprehensive approach.